It has been detected in central nervous system tissues, peripheral organs, and various biological fluids across multiple animal models, although its biosynthetic origin and precursor structure remain incompletely characterised
A spokesperson for Hims & Hers did not immediately respond to a request for comment
M., Campbell, S
It's designed to work in harmony with the bodys own signaling mechanisms to support repair, balance, and resilienceparticularly in tissues like the gut, joints, and muscles
PT-141 was FDA-approved in 2019 under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, representing the first melanocortin receptor agonist approved for this indication
Trial Registration ClinicalTrials.gov identifier, NCT05435677